Vicarious Surgical (NYSE:RBOT) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Vicarious Surgical (NYSE:RBOT) from a sell rating to a hold rating in a report issued on Sunday morning.

A number of other analysts have also recently commented on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, January 21st. BTIG Research reaffirmed a “neutral” rating on shares of Vicarious Surgical in a research report on Friday, December 12th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $7.00.

Vicarious Surgical Stock Down 3.7%

RBOT opened at $1.98 on Friday. The stock has a market capitalization of $12.94 million, a price-to-earnings ratio of -0.22 and a beta of 1.54. The firm has a 50 day moving average price of $2.41 and a 200-day moving average price of $4.65. Vicarious Surgical has a twelve month low of $1.80 and a twelve month high of $16.35.

Vicarious Surgical (NYSE:RBOT) last posted its earnings results on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, topping analysts’ consensus estimates of ($2.37) by $0.46. As a group, analysts expect that Vicarious Surgical will post -10.89 earnings per share for the current year.

Institutional Trading of Vicarious Surgical

Institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC lifted its holdings in Vicarious Surgical by 26.0% in the 4th quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock worth $88,000 after purchasing an additional 8,344 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Vicarious Surgical by 22.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after acquiring an additional 3,615 shares during the last quarter. Connective Capital Management LLC bought a new stake in Vicarious Surgical during the third quarter worth approximately $169,000. Finally, DNB Asset Management AS lifted its stake in shares of Vicarious Surgical by 12.1% in the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after purchasing an additional 3,154 shares during the last quarter. Hedge funds and other institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.